chr1-55039879-A-ACTG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_174936.4(PCSK9):​c.63_65dupGCT​(p.Leu22dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 1,557,874 control chromosomes in the GnomAD database, including 14,501 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L22L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.15 ( 1818 hom., cov: 31)
Exomes 𝑓: 0.14 ( 12683 hom. )

Consequence

PCSK9
NM_174936.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: -0.246

Publications

14 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_174936.4
BP6
Variant 1-55039879-A-ACTG is Benign according to our data. Variant chr1-55039879-A-ACTG is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.63_65dupGCTp.Leu22dup
disruptive_inframe_insertion
Exon 1 of 12NP_777596.2
PCSK9
NM_001407240.1
c.63_65dupGCTp.Leu22dup
disruptive_inframe_insertion
Exon 1 of 13NP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.63_65dupGCTp.Leu22dup
disruptive_inframe_insertion
Exon 1 of 12NP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.63_65dupGCTp.Leu22dup
disruptive_inframe_insertion
Exon 1 of 12ENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.420_422dupGCTp.Leu141dup
disruptive_inframe_insertion
Exon 1 of 12ENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.63_65dupGCTp.Leu22dup
disruptive_inframe_insertion
Exon 1 of 13ENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
23110
AN:
152038
Hom.:
1811
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.293
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.171
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.0863
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.143
GnomAD2 exomes
AF:
0.122
AC:
19607
AN:
161082
AF XY:
0.123
show subpopulations
Gnomad AFR exome
AF:
0.180
Gnomad AMR exome
AF:
0.0770
Gnomad ASJ exome
AF:
0.161
Gnomad EAS exome
AF:
0.115
Gnomad FIN exome
AF:
0.0898
Gnomad NFE exome
AF:
0.129
Gnomad OTH exome
AF:
0.120
GnomAD4 exome
AF:
0.140
AC:
197297
AN:
1405720
Hom.:
12683
Cov.:
30
AF XY:
0.140
AC XY:
97431
AN XY:
694280
show subpopulations
African (AFR)
AF:
0.201
AC:
6452
AN:
32166
American (AMR)
AF:
0.0817
AC:
2993
AN:
36632
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
4189
AN:
25156
East Asian (EAS)
AF:
0.122
AC:
4506
AN:
36930
South Asian (SAS)
AF:
0.146
AC:
11644
AN:
79788
European-Finnish (FIN)
AF:
0.0938
AC:
4583
AN:
48876
Middle Eastern (MID)
AF:
0.125
AC:
595
AN:
4746
European-Non Finnish (NFE)
AF:
0.142
AC:
154204
AN:
1083118
Other (OTH)
AF:
0.139
AC:
8131
AN:
58308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
12182
24364
36545
48727
60909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5758
11516
17274
23032
28790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.152
AC:
23137
AN:
152154
Hom.:
1818
Cov.:
31
AF XY:
0.148
AC XY:
11020
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.208
AC:
8628
AN:
41518
American (AMR)
AF:
0.108
AC:
1650
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
593
AN:
3466
East Asian (EAS)
AF:
0.114
AC:
591
AN:
5162
South Asian (SAS)
AF:
0.150
AC:
726
AN:
4824
European-Finnish (FIN)
AF:
0.0863
AC:
914
AN:
10596
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.139
AC:
9434
AN:
67976
Other (OTH)
AF:
0.144
AC:
303
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1037
2075
3112
4150
5187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0742
Hom.:
92

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hypercholesterolemia, familial, 1 (4)
-
-
4
not provided (4)
-
-
4
not specified (4)
-
-
3
Familial hypercholesterolemia (3)
-
-
2
Hypercholesterolemia, autosomal dominant, 3 (2)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.25
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35574083; hg19: chr1-55505552; COSMIC: COSV56160392; API